5 SIMPLE TECHNIQUES FOR MKENA

CDER’s latest proposal to withdraw the accelerated acceptance of Makena (HPC) was based on a big randomized demo that failed to substantiate the benefit of this drug to newborns or cut down the potential risk of PTB. In making the decision to suggest Makena’s withdrawal, CDER also reviewed outcomes from prior studies of progestins (HPC and va